FGFR1 and neoplasm: As a result of its ability to inhibit both paracrine and autocrine functions of FGF8b, ARPCA exerts a significant inhibitory effect on FGFR1 phosphorylation, cell proliferation, angiogenic and tumorigenic activity of S115 tumor grafts in immunodeficient male mice.